Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited completed a share repurchase on December 10, 2025, buying back 260,000 H shares on the Exchange. The shares were repurchased at prices ranging from HK$5.22 to HK$5.27, with a volume-weighted average price of HK$5.2396, for a total cost of HK$1,362,300. These repurchased shares will be held as treasury shares, increasing the total number of treasury shares to 29,309,200 from 29,049,200.

The repurchase represents a 0.0058% change in the number of issued shares (excluding treasury shares) relative to the opening balance. Following this event, the total number of issued shares (excluding treasury shares) stands at 4,493,023,124, down from 4,493,283,124. The total number of issued shares, including treasury shares, remains at 4,522,332,324.

The company holds a repurchase mandate authorized on May 27, 2025, allowing for the repurchase of up to 451,560,392 shares. To date, 22,660,800 shares have been repurchased on the Exchange, representing 5.0183% of the issued shares (excluding treasury shares) at the mandate's date. A moratorium period for new share issues or treasury share sales extends until January 9, 2026.